NNVC
NanoViricides·AMEX
--
--(--)
--
--(--)
NNVC fundamentals
NanoViricides (NNVC) released its earnings on Sep 27, 2024: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), missed estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Sep 27, 2024
EPS
Actual | -0.17 | -0.15 | -0.14 | -0.15 | -0.17 | -0.18 | -0.51 | |||||||||||
Forecast | -0.23 | -0.14 | -0.16 | -0.15 | -0.17 | -0.17 | -0.19 | -0.15 | -0.31 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +34.78% | 0.00% | +6.25% | 0.00% | 0.00% | 0.00% | +5.26% | -240.00% | 0.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | -- | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for NanoViricides year over year?What does NanoViricides do and what are its main business segments?What factors drove the changes in NanoViricides's revenue and profit?What were the key takeaways from NanoViricides's earnings call?Did NanoViricides beat or miss consensus estimates last quarter?What were the key takeaways from NanoViricides’s earnings call?What guidance did NanoViricides's management provide for the next earnings period?What is NanoViricides's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
